Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.
AuthorsNolen BM, Marks JR, Ta'san S, Rand A, Luong TM, Wang Y, Blackwell K, Lokshin AE
JournalBreast Cancer Res
PubMed ID18474099
Neoadjuvant chemotherapy has become the standard of care for the diverse population of women diagnosed with locally advanced breast cancer. Serum biomarker levels are increasingly being investigated for their ability to predict therapy response and aid in the development of individualized treatment regimens. Multianalyte profiles may offer greater predictive power ... More